These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21404609)

  • 1. [Migraine: advances in the pathophysiology and treatment].
    Shimizu T; Shibata M; Suzuki N
    Rinsho Shinkeigaku; 2011 Feb; 51(2):103-9. PubMed ID: 21404609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perspective of pathophysiology and treatment of migraine].
    Shimizu T; Suzuki N
    Brain Nerve; 2012 Jan; 64(1):59-64. PubMed ID: 22223502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGRP receptor antagonism and migraine therapy.
    Edvinsson L; Warfvinge K
    Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of calcitonin gene-related peptide receptors in cortical spreading depression.
    Tozzi A; de Iure A; Di Filippo M; Costa C; Caproni S; Pisani A; Bonsi P; Picconi B; Cupini LM; Materazzi S; Geppetti P; Sarchielli P; Calabresi P
    Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18985-90. PubMed ID: 23112192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system.
    Citak A; Kilinc E; Torun IE; Ankarali S; Dagistan Y; Yoldas H
    Cephalalgia; 2022 Nov; 42(13):1375-1386. PubMed ID: 35861239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic mechanisms of migraine and its acute treatment.
    Edvinsson L; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment.
    Moskowitz MA
    Funct Neurol; 2007; 22(3):133-6. PubMed ID: 17925161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of migraine chronification].
    Shibata M
    Rinsho Shinkeigaku; 2013; 23(11):1220-2. PubMed ID: 24291936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
    Wang M
    Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
    Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
    Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of calcitonin gene-related peptide on the increase in transient receptor potential vanilloid-1 levels in trigeminal ganglion and trigeminal nucleus caudalis activation of rat.
    Chatchaisak D; Srikiatkhachorn A; Maneesri-le Grand S; Govitrapong P; Chetsawang B
    J Chem Neuroanat; 2013 Jan; 47():50-6. PubMed ID: 23123284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CGRP in Migraine.
    Edvinsson L
    Handb Exp Pharmacol; 2019; 255():121-130. PubMed ID: 30725283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGRP-receptor antagonism in migraine treatment.
    Edvinsson L; Petersen KA
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):240-6. PubMed ID: 17691979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interactions between transient receptor potential M8 and transient receptor potential V1 in the trigeminal system: Relevance to migraine pathophysiology.
    Kayama Y; Shibata M; Takizawa T; Ibata K; Shimizu T; Ebine T; Toriumi H; Yuzaki M; Suzuki N
    Cephalalgia; 2018 Apr; 38(5):833-845. PubMed ID: 28554243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms underlying migraine chronification].
    Shibata M
    Rinsho Shinkeigaku; 2012; 52(11):1012-3. PubMed ID: 23196500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.